Kim HS - Search Results

1

Targeted Yttrium 89-Doxorubicin Drug-Eluting Bead-A Safety and Feasibility Pilot Study in a Rabbit Liver Cancer Model.

Ludwig JM, Xing M, Gai Y, Sun L, Zeng D, Kim HS. Ludwig JM, et al. Among authors: kim hs. Mol Pharm. 2017 Aug 7;14(8):2824-2830. doi: 10.1021/acs.molpharmaceut.7b00336. Epub 2017 Jul 25. Mol Pharm. 2017. PMID: 28700244 Free PMC article.

2

Safety and feasibility of same-day discharge of patients with unresectable hepatocellular carcinoma treated with doxorubicin drug-eluting bead transcatheter chemoembolization.

Prajapati HJ, Rafi S, El-Rayes BF, Kauh JS, Kooby DA, Kim HS. Prajapati HJ, et al. Among authors: kim hs. J Vasc Interv Radiol. 2012 Oct;23(10):1286-93.e1. doi: 10.1016/j.jvir.2012.07.003. J Vasc Interv Radiol. 2012. PMID: 22999748

3

Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.

Prajapati HJ, Dhanasekaran R, El-Rayes BF, Kauh JS, Maithel SK, Chen Z, Kim HS. Prajapati HJ, et al. Among authors: kim hs. J Vasc Interv Radiol. 2013 Mar;24(3):307-15. doi: 10.1016/j.jvir.2012.11.026. Epub 2013 Jan 29. J Vasc Interv Radiol. 2013. PMID: 23375519

4

90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness.

Xing M, Kokabi N, Camacho JC, Kooby DA, El-Rayes BF, Kim HS. Xing M, et al. Among authors: kim hs. J Comp Eff Res. 2013 Jul;2(4):435-44. doi: 10.2217/cer.13.37. J Comp Eff Res. 2013. PMID: 24236684 Free article. Review.

5

Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.

Camacho JC, Kokabi N, Xing M, Prajapati HJ, El-Rayes B, Kim HS. Camacho JC, et al. Among authors: kim hs. J Vasc Interv Radiol. 2014 Feb;25(2):256-65. doi: 10.1016/j.jvir.2013.10.056. J Vasc Interv Radiol. 2014. PMID: 24461131

6

A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.

Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS. Kokabi N, et al. Among authors: kim hs. J Vasc Interv Radiol. 2014 Feb;25(2):277-87. doi: 10.1016/j.jvir.2013.11.007. J Vasc Interv Radiol. 2014. PMID: 24461133

7

Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis.

Kokabi N, Camacho JC, Xing M, Qiu D, Kitajima H, Mittal PK, Kim HS. Kokabi N, et al. Among authors: kim hs. Abdom Imaging. 2014 Oct;39(5):969-78. doi: 10.1007/s00261-014-0127-8. Abdom Imaging. 2014. PMID: 24740759

8

Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.

Xing M, Kooby DA, El-Rayes BF, Kokabi N, Camacho JC, Kim HS. Xing M, et al. Among authors: kim hs. J Surg Oncol. 2014 Aug;110(2):182-96. doi: 10.1002/jso.23619. Epub 2014 Apr 24. J Surg Oncol. 2014. PMID: 24760444 Review.

9

Selective Internal Yttrium-90 Radioembolization Therapy (90Y-SIRT) Versus Best Supportive Care in Patients With Unresectable Metastatic Melanoma to the Liver Refractory to Systemic Therapy: Safety and Efficacy Cohort Study.

Xing M, Prajapati HJ, Dhanasekaran R, Lawson DH, Kokabi N, Eaton BR, Kim HS. Xing M, et al. Among authors: kim hs. Am J Clin Oncol. 2017 Feb;40(1):27-34. doi: 10.1097/COC.0000000000000109. Am J Clin Oncol. 2017. PMID: 25089529

10

PET response criteria for solid tumors predict survival at three months after intra-arterial resin-based 90Yttrium radioembolization therapy for unresectable intrahepatic cholangiocarcinoma.

Camacho JC, Kokabi N, Xing M, Schuster DM, Kim HS. Camacho JC, et al. Among authors: kim hs. Clin Nucl Med. 2014 Nov;39(11):944-50. doi: 10.1097/RLU.0000000000000557. Clin Nucl Med. 2014. PMID: 25140563

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,213 results

Search Page

Filters